Humana price target raised to $560 from $555 at Stephens

Stephens analyst Scott Fidel raised the firm’s price target on Humana to $560 from $555 and keeps an Overweight rating on the shares. Humana delivered “solid” Q2 results and not long reaffirmed its FY23 adjusted EPS guidance, but also committed to delivering FY24 EPS growth in line with its long term growth algorithm, the analyst tells investors. The company also provided comfort by disclosing MA utilization environment appears to be stabilizing, Stephens says.